50380 Federal Register / Vol. 70, No. 165 / Friday, August 26, 2005 / Notices 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel Review of Research Program 

Projects (P01s). 

Date: September 27, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hawthorne Suites Hotel, 300 

Meredith Drive, Research Triangle Park, NC 

27713. 

Contact Person: Janice B. Allen, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, Division of Extramural 

Research and Training, Nat. Institute of 

Environmental Health Science, P.O. Box 

12233, MD EC–30/Room 3170B, Research 

Triangle Park, NC 27709, (919) 541–7556.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 93.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education; 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards; 93.114, 

Applied Toxicological Research and Testing, 

National Institutes of Health, HHS)

Dated: August 17, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 05–17014 Filed 8–25–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel Review of an Unsolicited 

Revised Tyrosine Phosphatase Program 

Project Application 

Date: September 20, 2005. 

Time: 10 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

3118, Bethesda, MD 20817. (Telephone 

Conference Call.) 

Contact Person: Quirijn Vos, PhD, 

Scientific Review Administrator, Scientific 

Review Program, Division of Extramural 

Activities, NIAID/NIH/DHHS, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892–7616, (301) 496–2550 

qvos@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS)

Dated: August 19, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 05–17018 Filed 8–25–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Listing of Members of the 

National Institutes of Health’s Senior 

Executive Service Performance Review 

Board (PRB) 

The National Institutes of Health 

(NIH) announces the persons who will 

serve on the National Institutes of 

Health’s Senior Executive Service 

Performance Review Board. This action 

is being taken in accordance with Title 

5, U.S.C., 4314(c)(4), which requires that 

members of performance review board 

be appointed in a manner to ensure 

consistency, stability, and objectivity in 

performance appraisals, and requires 

that notice of the appointment of an 

individual to serve as a member be 

published in the Federal Register. 

The following persons will serve on 

the NIH Performance Review Board, 

which oversees the evaluation of 

performance appraisals of NIH Senior 

Executive Service (SES) members: Ms. 

Colleen Barros (Chair), Dr. Norka Ruiz 

Bravo, Dr. Michael Gottesman, Ms. Lynn 

Hellinger, Dr. Barry Hoffer, Dr. Sharon 

Hrynkow, Dr. Betsy Humphreys, Dr. 

Raynard Kington, Dr. Lore Anne 

McNicol, Dr. Marcelle MorrisonBogorad, Ms. Martha Pine, and Dr. Brent 

Stanfield. 

For further information about the NIH 

Performance Review Board, contact the 

Office of Human Resources, Workforce 

Relations Division, National Institutes of 

Health, Building 31/B3C07, Bethesda, 

Maryland 20892, telephone (301) 402–

9203 (not a toll-free number).

Dated: August 16, 2005. 

Elias A. Zerhouni, 

Director, National Institutes of Health.

[FR Doc. 05–17019 Filed 8–25–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

documents, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Drug and Alcohol Services Information 

System (DASIS) (OMB No. 0930–

0106)—Revision 

The DASIS consists of three related 

data systems: The Inventory of 

Substance Abuse Treatment Services (I–

SATS); the National Survey of 

Substance Abuse Treatment Services 

(N–SSATS), and the Treatment Episode 

Data Set (TEDS). The I–SATS includes 

all substance abuse treatment facilities 

known to SAMHSA. The N–SSATS is 

an annual survey of all substance abuse 

treatment facilities listed in the I–SATS. 

The TEDS is a compilation of clientlevel admission data and discharge data 

submitted by States on clients treated in 

facilities that receive State funds. 

Together, the three DASIS components 

provide information on the location, 

scope and characteristics of all known 

drug and alcohol treatment facilities in 

the United States, the number of 

persons in treatment, and the 

characteristics of clients receiving 

services at publicly-funded facilities. 

This information is needed to assess the 

nature and extent of these resources, to 

identify gaps in services, to provide a 

database for treatment referrals, and to 

assess demographic and substancerelated trends in treatment. In addition, 

SAMHSA and the State substance abuse 

officials participating in SAMHSA’s 

December 2004 meeting on National 

Outcome Measures (NOMS) agreed that 

several NOMS data elements to assess 

the performance of the Substance Abuse 

Federal Register / Vol. 70, No. 165 / Friday, August 26, 2005 / Notices 50381

Prevention and Treatment (SAPT) Block 

Grant will be collected in TEDS. 

The request for OMB approval 

includes a request to conduct the 2006 

N–SSATS survey and the 2006 Mini-N–

SSATS. The Mini-N–SSATS is a 

procedure for collecting services data 

from newly identified facilities between 

main cycles of the survey and will be 

used to improve the listing of treatment 

facilities in the on-line treatment facility 

Locator. The 2006 N–SSATS 

questionnaire will include several new 

items, including the addition of nicotine 

replacement therapy and psychiatric 

medications to the pharmacotherapies 

list and the addition of new services to 

the list of services provided. The request 

also includes a request to conduct a 

pretest of the 2007 N–SSATS 

questionnaire in 2006. The 2007 pretest 

questionnaire will include several 

changes, including the modification of 

the treatment categories to better reflect 

the practices and terminology currently 

used in the treatment field; modification 

of the detoxification question, including 

the addition of a follow-up question on 

whether the facility uses drugs in 

detoxification and for which substances; 

the addition of questions on treatment 

approaches and behavioral 

interventions; the addition of a question 

on quality control procedures used by 

the facility; and, the addition of a 

question on whether the facility accepts 

ATR vouchers and how many annual 

admissions were funded by ATR 

vouchers. Following the pretest of the 

2007 N–SSATS, a separate request for 

OMB approval will be submitted for the 

2007 and 2008 N–SSATS, including the 

Mini-N–SSATS for those years. 

The request for OMB approval will 

also include the addition of several new 

NOMS data elements to the TEDS 

client-level record. To the extent that 

states already collect the elements from 

their treatment providers, the following 

elements will be included in the TEDS 

data collection: Number of arrests at 

admission and at discharge; substances 

used/frequency of use at discharge; 

employment at discharge; and living 

arrangement at discharge.

Estimated annual burden for the 

DASIS activities is shown below:

Type of respondent and activity Number of

respondents 

Responses 

per

respondent 

Hours per

response 

Total burden 

hours 

States: 

TEDS Admission Data .............................................................................. 52 4 6 1,248 

TEDS Discharge Data .............................................................................. 40 4 8 1,280 

TEDS Discharge Crosswalks ................................................................... 5 1 10 50 

I–SATS Update ......................................................................................... 56 67 .08 300 

State subtotal .................................................................................... 56 2,878 

Facilities:.

I–SATS Update ......................................................................................... 100 1 .08 8 

Pretest of N–SSATS revisions ................................................................. 200 1 .17 34 

N–SSATS questionnaire ........................................................................... 17,000 1 .2 3,400 

Augmentation screener ............................................................................ 1,000 1 .08 80 

Mini-N–SSATS .......................................................................................... 700 1 .13 91 

Facility subtotal .................................................................................. 19,000 3,613 

Total ........................................................................................... 19,056 6,491 

Written comments and 

recommendations concerning the 

proposed information collection should 

be sent by September 26, 2005 to: 

SAMHSA Desk Officer, Human 

Resources and Housing Branch, Office 

of Management and Budget, New 

Executive Office Building, Room 10235, 

Washington, DC 20503; due to potential 

delays in OMB’s receipt and processing 

of mail sent through the U.S. Postal 

Service, respondents are encouraged to 

submit comments by fax to: 202–395–

6974.

Dated: August 12, 2005. 

Anna Marsh, 

Executive Officer, SAMHSA.

[FR Doc. 05–16989 Filed 8–25–05; 8:45 am] 

BILLING CODE 4162–20–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration (SAMHSA) 

Notice: Request for Comments; 

National Registry of Evidence-Based 

Programs and Practices (NREPP)

Authority: Sec. 501, Pub. L. 106–310

SUMMARY: The Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) is committed to preventing 

the onset and reducing the progression 

of mental illness, substance abuse and 

substance related problems among all 

individuals, including youth. As part of 

this effort, SAMHSA is expanding and 

refining the agency’s National Registry 

of Evidence-based Programs and 

Practices (NREPP) so that the system 

serves as a leading national resource for 

contemporary and reliable information 

on the scientific basis and practicality of 

interventions to prevent and/or treat 

mental illness and substance use and 

abuse. 

NREPP represents a major agency 

activity within SAMHSA’s Science to 

Service initiative. The initiative seeks to 

accelerate the translation of research 

into practice by promoting the 

implementation of effective, evidencebased interventions for preventing and/

or treating mental disorders and 

substance use and abuse. Of equal 

measure, the initiative emphasizes the 

essential role of the services community 

in providing input and feedback to 

influence and better frame the research 

questions and activities pursued by 

researchers in these areas. 

Through SAMHSA’s Science to 

Service initiative, the agency ultimately 

seeks to develop a range of tools that 

will facilitate evidence-based decisionmaking in substance abuse prevention, 

mental health promotion, and the 

treatment of mental and substance use 

disorders. In addition to NREPP, 

SAMHSA is developing an 

informational guide of web-based